Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Telix Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$5.94B | 117x | 0.15 | A$17.53 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mesoblast | Sydney | Healthcare | Biotechnology & Medical Research | A$3.07B | -16.9x | 2.75 | A$2.38 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31% Upside | Upgrade to Pro+ | |
Clarity Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$1.36B | -18.2x | 0.8 | A$3.89 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PYC Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$764.07M | -11.9x | 0.2 | A$1.32 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Immutep | Sydney | Healthcare | Biotechnology & Medical Research | A$386.05M | -8.1x | -0.6 | A$0.26 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CogState Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$283.53M | 26.1x | 0.59 | A$1.67 | -0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 10.4% Upside | Upgrade to Pro+ | |
Dimerix | Sydney | Healthcare | Biotechnology & Medical Research | A$279.07M | -9.7x | 0.23 | A$0.47 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tetratherix | Sydney | Healthcare | Biotechnology & Medical Research | A$229.01M | -0x | A$4.53 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9% Upside | Upgrade to Pro+ | ||
Race Oncology | Sydney | Healthcare | Biotechnology & Medical Research | A$206.76M | -26.2x | -0.78 | A$1.25 | 4.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avita Medical Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$199.77M | -2.5x | 3.26 | A$1.62 | 1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.2% Upside | Upgrade to Pro+ | |
Paradigm Biopharmaceuticals Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$123.20M | -6.6x | -0.1 | A$0.30 | -6.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Alterity Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$119.70M | -3.3x | -0.27 | A$0.01 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bioxyne Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$112.57M | 39.2x | 0.38 | A$0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arovella Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$105.87M | -14.8x | -0.33 | A$0.09 | 2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amplia Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$93.89M | -9.1x | -1.9 | A$0.19 | -5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Argenica Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$93.76M | -15.1x | -0.79 | A$0.70 | 2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pacific Edge | Sydney | Healthcare | Biotechnology & Medical Research | A$92.66M | -3.5x | 2.69 | A$0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Imugene Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$77.89M | -0.5x | 0.02 | A$0.28 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Actinogen Medical | Sydney | Healthcare | Biotechnology & Medical Research | A$76.25M | -8.4x | -0.16 | A$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Anteo Diagnostics | Sydney | Healthcare | Biotechnology & Medical Research | A$64.93M | -6.8x | -0.21 | A$0.03 | 8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LTR Pharma | Sydney | Healthcare | Biotechnology & Medical Research | A$64.25M | -11.7x | 0.04 | A$0.35 | -2.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clever Culture Systems | Sydney | Healthcare | Biotechnology & Medical Research | A$64.07M | -60x | -0.79 | A$0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nyrada | Sydney | Healthcare | Biotechnology & Medical Research | A$58.15M | -4.6x | -0.48 | A$0.28 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neuroscientific Biopharma | Sydney | Healthcare | Biotechnology & Medical Research | A$56.54M | 20.4x | 0.84 | A$0.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Proteomics Intl Labs | Sydney | Healthcare | Biotechnology & Medical Research | A$54.83M | -6.5x | -3.42 | A$0.34 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Tryptamine Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$48.94M | -2.5x | A$0.03 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Island Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$48.21M | -6.2x | -1.5 | A$0.21 | 16.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Syntara | Sydney | Healthcare | Biotechnology & Medical Research | A$43.94M | -3.3x | -0.09 | A$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Prescient Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$43.13M | -5x | -0.58 | A$0.04 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cynata Therapeutics Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$42.93M | -4.1x | -0.12 | A$0.19 | -2.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Holista CollTech Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$32.83M | -245x | -3.42 | A$0.10 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rhythm Biosciences | Sydney | Healthcare | Biotechnology & Medical Research | A$31.25M | -10.5x | -0.19 | A$0.11 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Noxopharm | Sydney | Healthcare | Biotechnology & Medical Research | A$30.68M | -13.3x | -0.16 | A$0.10 | -4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
IDT Australia Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$29.16M | -7.7x | -0.14 | A$0.07 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Emyria | Sydney | Healthcare | Biotechnology & Medical Research | A$27.52M | -8.2x | -0.21 | A$0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avecho Bio | Sydney | Healthcare | Biotechnology & Medical Research | A$22.21M | -7x | -0.21 | A$0.007 | -14.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BTC Health | Sydney | Healthcare | Biotechnology & Medical Research | A$19.84M | 4.6x | 0.03 | A$0.06 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BPH Energy Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$15.84M | 1.2x | 0 | A$0.01 | -7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Neurotech Intl | Sydney | Healthcare | Biotechnology & Medical Research | A$14.69M | -1.2x | 0.01 | A$0.01 | -7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Algorae Pharmaceuticals | Sydney | Healthcare | Biotechnology & Medical Research | A$13.50M | -10x | -0.22 | A$0.007 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Invion Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$12.39M | -0.9x | 0 | A$0.14 | 55.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Percheron Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$10.87M | -0.6x | 0.31 | A$0.010 | 11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -9.1% Downside | Upgrade to Pro+ | |
Chimeric Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$9.76M | -0.3x | -0.14 | A$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cambium Bio | Sydney | Healthcare | Biotechnology & Medical Research | A$6.58M | A$0.36 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Invex Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$5.64M | -11.9x | -0.27 | A$0.10 | 5.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zelira Therapeutics | Sydney | Healthcare | Biotechnology & Medical Research | A$4.88M | -1x | -0.01 | A$0.41 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Adalta | Sydney | Healthcare | Biotechnology & Medical Research | A$4.45M | -0.5x | -0.02 | A$0.004 | 33.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biotron Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$3.98M | -2.5x | -0.04 | A$0.003 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vectus Biosystems | Sydney | Healthcare | Biotechnology & Medical Research | A$3.20M | -1.8x | -0.15 | A$0.06 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Patrys Ltd | Sydney | Healthcare | Biotechnology & Medical Research | A$2.96M | -1.7x | -0.02 | A$0.001 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |